TANVEX BIOPHARMA, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.55 TWD | +1.25% |
|
+13.36% | -31.57% |
| 06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
| 06-19 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
Quotes 5-day view
End-of-day quote Taiwan S.E.| 2024-06-21 | 2024-06-24 | 2024-06-25 | 2024-06-26 | Today | 2024-06-26 | |
|---|---|---|---|---|---|---|
| Last | 40.8 NT$ | 43.85 NT$ | 42.1 NT$ | 44 NT$ | 44.55 NT$ | 44.55 NT$ |
| Volume | 152 101 | 565 720 | 119 066 | 244 001 | 217 546 | 217 546 |
| Change | +2.77% | +7.48% | -3.99% | +4.51% | +1.25% | +1.25% |
| Opening | 40.05 | 41.60 | 43.00 | 42.40 | 44.95 | 44.95 |
| High | 41.05 | 44.85 | 43.20 | 44.30 | 45.90 | 45.9 |
| Low | 40.05 | 41.30 | 41.60 | 42.35 | 44.40 | 44.4 |
Performance
| 1 day | +1.25% | ||
| 1 week | +13.36% | ||
| Current month | +13.65% | ||
| 1 month | +17.24% | ||
| 3 months | -7.38% | ||
| 6 months | -32.40% | ||
| Current year | -31.57% | ||
| 1 year | -41.92% | ||
| 3 years | -74.77% | ||
| 5 years | -79.78% |
Volumes
marketsDaily volume
217 546
Avg. Volume 20 sessions
152 765
Avg. Volume 20 sessions TWD
6 805 680.75
Avg. Volume 20 sessions USD
209 199.82
Record volume 1
3 787 967
Record volume 2
3 152 645
Record volume 3
3 130 498
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (TWD)
221 345 217
Capitalization (USD)
221 345 217
Net sales ()
61
Number of employees
167
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
59.81 %
Free-Float capitalization (TWD)
132 395 208
Free-Float capitalization (USD)
132 395 208
Average Daily Capital Traded
3.07%
Highs and lows
1 week
40.05
45.90
1 month
37.9045.90
Current year
35.0566.50
1 year
35.0578.00
3 years
35.05245.22
5 years
35.05299.78
10 years
35.051 034.21
Indicators
Moving average 5 days
43.06
Moving average 20 days
41.18
Moving average 50 days
42.41
Moving average 100 days
49.46
Price spread / (MMA5)
-3.34%
Price spread / (MMA20)
-7.56%
Price spread / (MMA50)
-4.80%
Price spread / (MMA100)
+11.02%
STIM
RSI 9 days
66.63
RSI 14 days
60.99
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.25% | +13.36% | -31.57% | -41.92% | 221M | ||
| +0.12% | +0.63% | +16.58% | +36.65% | 122B | ||
| -1.53% | +1.10% | +20.22% | +47.45% | 115B | ||
| -0.79% | +16.09% | +21.22% | +20.17% | 26.64B | ||
| -2.27% | -5.97% | -23.49% | -23.72% | 19.91B | ||
| -0.70% | -1.03% | -17.47% | -30.36% | 16.32B | ||
| -2.19% | -6.22% | -45.95% | -38.65% | 15.52B | ||
| +0.61% | -5.87% | -18.82% | -18.79% | 15.49B | ||
| -0.41% | +26.56% | +62.09% | +46.90% | 14.83B | ||
| -0.32% | +1.08% | +2.85% | +43.12% | 13.67B | ||
| -2.06% | +4.10% | +117.36% | +237.31% | 11.12B | ||
| -1.15% | +8.87% | -26.18% | -38.44% | 8.18B | ||
| +2.49% | +5.37% | +22.08% | +50.18% | 8.17B | ||
| -0.46% | +34.39% | +132.98% | +257.23% | 7.79B | ||
| +0.70% | +10.01% | +6.22% | +51.81% | 7.61B | ||
| +2.14% | -4.49% | -6.11% | +21.85% | 7.1B | ||
| Average | -0.29% | +7.02% | +14.50% | +38.80% | ||
| Weighted average by Cap. | -0.66% | +4.44% | +15.68% | +37.05% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -31.57% | ||
| 2023 | -38.13% | ||
| 2022 | -39.59% | ||
| 2021 | +55.35% | ||
| 2020 | -16.42% | ||
| 2019 | -28.40% | ||
| 2018 | -35.50% | ||
| 2017 | -37.44% | ||
| 2016 | -35.73% | ||
| 2015 | +86.82% |
- Stock Market
- Equities
- 6541 Stock
- Quotes Tanvex BioPharma, Inc.
